EQ Equillium, Inc.
$1.42▲ +4.41%
Healthcare
Other
Volume 227.3K
Avg Volume (10D) 683.8K
Key Metrics & Fundamentals
Market Cap
$111.28M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.76 - 3.54
% vs 50 MA
-21.22%
% vs 200 MA
-31.60%
RSI-14
46.2
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.26
Free Cash Flow
-$4.18M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.13M
COGS
–
Operating Exp
$5.16M
Operating Income
-$5.16M
EBIT
-$5.16M
Pretax Income
-$4.69M
Net Income
-$4.69M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
GlobeNewswire · Oct 26, 2026 8:30 AM ET
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
GlobeNewswire · Oct 6, 2026 4:05 PM ET
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Equillium Announces Poster Presentations at the 7th International AHR Conference
GlobeNewswire · Sep 29, 2026 4:05 PM ET
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
MarketBeat · Sep 27, 2026 6:01 PM ET
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire · Sep 16, 2026 8:30 AM ET
Equillium to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 8:30 AM ET
EQ Inc. Reports Second Quarter 2026 Financial Results
ACCESS Newswire · Aug 20, 2026 5:00 PM ET
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Aug 13, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Dec 2024
See EQ's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.